Clinical trials
Recruiting Hypoparathyroidism trials in the United States
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
8 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2022 | 1 |
| 2026 | 6 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Recruiting | 8 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Ascendis Pharma A/S | 2 |
| Ascendis Pharma Bone Diseases A/S | 1 |
| Bettina Mittendorfer | 1 |
| Calcilytix Therapeutics, Inc., a BridgeBio company | 1 |
| Columbia University | 1 |
| MBX Biosciences | 1 |
| Peter Stock | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Hypoparathyroidism | 8 |
| Bone Diseases, Metabolic | 1 |
| Cachexia | 1 |
| Cystic Fibrosis | 1 |
| Diabetes Mellitus | 1 |
| Endocrine System Diseases | 1 |
| Heart Failure | 1 |
| Hyperparathyroidism | 1 |
| Myocardial Ischemia | 1 |
| Obesity | 1 |
Trials
Showing 1 to 8 of 8. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.